Literature DB >> 19457142

Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection.

P K Chandra1, A Biswas, S Datta, A Banerjee, R Panigrahi, S Chakrabarti, B K De, R Chakravarty.   

Abstract

Hepatitis B genotype D (HBV/D) is the most widespread genotype and exists as at least five subgenotypes (HBV/D1-D5). However, little is known about the association of virological characteristics with clinical differences among HBV/D subgenotypes. To investigate the virological characteristics of these subgenotypes and their clinical implications, we selected a cohort of 109 genotype D infected individuals from the state of West Bengal, India, including 68 HBsAg positive patients and 41 with occult HBV infection. Among the HBsAg positive subjects 28 had chronic hepatitis B virus infection, 40 were asymptomatic carriers based on clinical examination, liver function test and ultrasonograph results. Overall, HBV/D1 was found in 17%, HBV/D2 in 29%, HBV/D3 in 34% and HBV/D5 in 20% of the cases. HBV/D1 was significantly associated with chronic liver disease (P = 0.01), and in this subgenotype A1896 (PreC mutations) were most common. Although BCP mutations (A/C1753 and T1762/A1764) were found to be frequently associated with HBV/D2 (33% and 33%) and D5 (47% and 59%), no apparent clinical correlation was observed. On the other hand, occult HBV infection was significantly associated with HBV/D3 infection, along with low level of BCP and PreC mutations and several non-synonymous substitutions in the catalytic reverse transcriptase (RT) domain of polymerase gene. Similar nucleotide substitutions in the surface (S) gene region were observed from both northern and eastern Indian HBV/D3 isolates. In conclusion, HBV/D subgenotypes differ in their mutational patterns in the S, polymerase and the BCP/PreC regions that may influence their clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457142     DOI: 10.1111/j.1365-2893.2009.01129.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  23 in total

Review 1.  Insights into human immunodeficiency virus-hepatitis B virus co-infection in India.

Authors:  Runu Chakravarty; Ananya Pal
Journal:  World J Virol       Date:  2015-08-12

Review 2.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Mutations in Hepatitis-B X-Gene Region: Chronic Hepatitis-B versus Cirrhosis.

Authors:  Farzaneh Salarnia; Sima Besharat; Sare Zhand; Naeme Javid; Behnaz Khodabakhshi; Abdolvahab Moradi
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Association of Interleukin-1β and Gene Polymorphisms with Liver Pathogenesis in Hepatitis B Virus Infection among Eastern Indian Population.

Authors:  Avik Biswas; Rajesh Panigrahi; Manisha Pal; Binay K De; Sekhar Chakrabarti; Mrinmoy K Ghosh; Bikash C Chandra Seth; Susanta Roychowdhury; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2013-12-04

5.  Clinical relevance and public health significance of hepatitis B virus genomic variations.

Authors:  Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

6.  Hepatitis B escape mutants in Scottish blood donors.

Authors:  Osmany Larralde; Brian Dow; Lisa Jarvis; Fiona Davidson; Juraj Petrik
Journal:  Med Microbiol Immunol       Date:  2012-12-29       Impact factor: 3.402

7.  Unique hepatitis B virus subgenotype in a primitive tribal community in eastern India.

Authors:  Sumantra Ghosh; Priyanka Banerjee; Arindam RoyChoudhury; Sumanta Sarkar; Alip Ghosh; Amal Santra; Soma Banerjee; Kausik Das; Bhagirathi Dwibedi; Shantanu K Kar; Vikas Gangadhar Rao; Jyothi T Bhat; Neeru Singh; Abhijit Chowdhury; Simanti Datta
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

8.  Characterization of hepatitis B virus (HBV) genotypes in patients from Rondônia, Brazil.

Authors:  Alcione O Santos; Mónica V Alvarado-Mora; Lívia Botelho; Deusilene S Vieira; João R Rebello Pinho; Flair J Carrilho; Eduardo R Honda; Juan M Salcedo
Journal:  Virol J       Date:  2010-11-12       Impact factor: 4.099

9.  Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion.

Authors:  Rajesh Panigrahi; Avik Biswas; Sibnarayan Datta; Arup Banerjee; Partha K Chandra; Pradip K Mahapatra; Bharat Patnaik; Sekhar Chakrabarti; Runu Chakravarty
Journal:  Virol J       Date:  2010-08-27       Impact factor: 4.099

10.  Hepatitis B virus genotyping: is the time ripe for routine clinical use?

Authors:  Kaushal Madan; Pankaj Tyagi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.